课题基金 / 基金详情

Assessment of Auditory Function in Patients with Parkinson Disease

Assessment of Auditory Function in Patients with Parkinson Disease
帕金森病患者听觉功能的评估
批准号:
8276843
负责人:
Robert Folmer
金额:
$0.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-07-01 至 2014-06-30

项目摘要

项目成果

Robert Folmer的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Few investigations of auditory function in patients with Parkinson Disease (PD) have been conducted or published. Results from a small number of studies indicate that PD patients experience auditory deficits (including hearing loss) with greater prevalence and severity than healthy control subjects of similar age. Some authors and clinicians recommend that auditory function should be evaluated routinely in Parkinson patients because such sensory manifestations of the disease are often not formally assessed, and thus are misdiagnosed or under- diagnosed. Untreated hearing loss or auditory processing deficits can contribute to communication problems that reduce the quality of life for Veterans with PD. The proposed study will use behavioral tests of auditory function, auditory event-related potentials (AERPs) and questionnaires to provide detailed assessments of auditory function in Parkinson patients. Findings from this pilot project will provide data necessary for the design of a full-scale Merit Review proposal that will include assessment of rehabilitative interventions for auditory deficits in this population. Objective: The long-range goal of this research program is to identify Veterans with Parkinson Disease (PD) who are at risk for auditory deficits related to their disease so that current difficulties can be addressed and further deterioration can be prevented or treated. The objective of this proposal is to assess peripheral and central auditory functions i patients with Parkinson Disease (PD). The central hypothesis of the proposed research is that deficits in auditory processing occur with greater prevalence and severity in Parkinson patients than in age-matched control subjects. Our hypothesis has been formulated on the basis of supportive preliminary studies. Specific Aims: We will test our central hypothesis and accomplish the objective of this application by pursuing the following specific aims: Specific Aim 1: Evaluate the peripheral hearing (auditory thresholds) of PD patients and compare the results to those from age-matched control subjects who do not have PD. Specific Aim 2: Evaluate central auditory processing, including speech perception ability, of PD patients and compare the results to those from age-matched control subjects who do not have PD. Study Design: Study groups will include 50 patients with Parkinson Disease and 50 age- and gender-matched healthy control subjects. All subjects will attend 3 appointments: 1) Initial evaluations and physical exam; 2) Peripheral and Central auditory testing; 3) Electrophysiological recordings. PD patients who take levodopa daily will undergo study procedures in the morning, within 3 hours of ingesting the medication. Impact: At the conclusion of this study, we will have a better understanding of auditory problems and deficits experienced by Parkinson patients. This information could be used to develop and assess interventions to improve auditory processing in patients who experience such deficits. Ultimately, these interventions might help to slow or even reverse functional degradation within the central auditory system. Data from the proposed study and related investigations would facilitate patient selection and outcome assessments for these and other rehabilitative interventions. Ultimately, these interventions will contribute to improved quality of life for Veterans and non-Veterans with PD. PUBLIC HEALTH RELEVANCE: Veterans with Parkinson Disease (PD) experience auditory deficits (including hearing loss) with greater prevalence and severity than healthy control subjects of similar age. The proposed study will use behavioral tests of auditory function, auditory event-related potentials (AERPs) and questionnaires to provide detailed assessments of auditory function in Parkinson patients. At the conclusion of this study, we will have a better understanding of auditory problems and deficits experienced by these patients. This information could be used to develop and assess interventions to improve auditory processing in Parkinson patients who experience such deficits. These interventions might help to slow or even reverse functional degradation within the central auditory system. Data from the proposed study and related investigations would facilitate patient selection and outcome assessments for these and other rehabilitative interventions. Ultimately, these interventions will contribute to improved quality of life for Veterans and non-Veterans with PD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Validation and Expansion of Established Norms for Measures of Tinnitus Perception
  • 批准号:
    10385707
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2015
  • 负责人:
    Robert Folmer
  • 依托单位:
Clinical Trial of Transcranial Magnetic Stimulation for Relief of Tinnitus
  • 批准号:
    8838113
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2011
  • 负责人:
    Robert Folmer
  • 依托单位:
Clinical Trial of Transcranial Magnetic Stimulation for Relief of Tinnitus
  • 批准号:
    8003655
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2011
  • 负责人:
    Robert Folmer
  • 依托单位:
Clinical Trial of Transcranial Magnetic Stimulation for Relief of Tinnitus
  • 批准号:
    8840052
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2011
  • 负责人:
    Robert Folmer
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: